Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis
The impact of a 4-week course of therapy with Uralyt-U (potassium-sodium hydrocitrate) on uric acid (UA) metabolic parameters was studied in patients with gout and nephrolithiasis. Elevated daily urinary excretion of UA was found to be directly correlated with its lower serum level after 4-week ther...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2012-03-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | http://mrj.ima-press.net/index.php/mrj/article/view/400 |
| id |
doaj-f572a38597fa4e44a9ebfefd365d8a16 |
|---|---|
| record_format |
Article |
| spelling |
doaj-f572a38597fa4e44a9ebfefd365d8a162021-07-02T07:57:46ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2012-03-010144481705Clinical experience with Uralyt-U used in patients with gout and nephrolithiasisM S EliseyevI S DenisovViktoria Georgiyevna BarskovaThe impact of a 4-week course of therapy with Uralyt-U (potassium-sodium hydrocitrate) on uric acid (UA) metabolic parameters was studied in patients with gout and nephrolithiasis. Elevated daily urinary excretion of UA was found to be directly correlated with its lower serum level after 4-week therapy with Uralyt-U (p < 0.05), resulting in improvement and normalization of UA metabolism. Uralyt-U therapy is safe and causes no worsening of the parameters of hepatic and renal function and electrolyte exchange.http://mrj.ima-press.net/index.php/mrj/article/view/400gouturate nephrolithiasishyperuricemia |
| collection |
DOAJ |
| language |
Russian |
| format |
Article |
| sources |
DOAJ |
| author |
M S Eliseyev I S Denisov Viktoria Georgiyevna Barskova |
| spellingShingle |
M S Eliseyev I S Denisov Viktoria Georgiyevna Barskova Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis Современная ревматология gout urate nephrolithiasis hyperuricemia |
| author_facet |
M S Eliseyev I S Denisov Viktoria Georgiyevna Barskova |
| author_sort |
M S Eliseyev |
| title |
Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis |
| title_short |
Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis |
| title_full |
Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis |
| title_fullStr |
Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis |
| title_full_unstemmed |
Clinical experience with Uralyt-U used in patients with gout and nephrolithiasis |
| title_sort |
clinical experience with uralyt-u used in patients with gout and nephrolithiasis |
| publisher |
IMA-PRESS LLC |
| series |
Современная ревматология |
| issn |
1996-7012 2310-158X |
| publishDate |
2012-03-01 |
| description |
The impact of a 4-week course of therapy with Uralyt-U (potassium-sodium hydrocitrate) on uric acid (UA) metabolic parameters was studied in patients with gout and nephrolithiasis. Elevated daily urinary excretion of UA was found to be directly correlated with its lower serum level after 4-week therapy with Uralyt-U (p < 0.05), resulting in improvement and normalization of UA metabolism. Uralyt-U therapy is safe and causes no worsening of the parameters of hepatic and renal function and electrolyte exchange. |
| topic |
gout urate nephrolithiasis hyperuricemia |
| url |
http://mrj.ima-press.net/index.php/mrj/article/view/400 |
| work_keys_str_mv |
AT mseliseyev clinicalexperiencewithuralytuusedinpatientswithgoutandnephrolithiasis AT isdenisov clinicalexperiencewithuralytuusedinpatientswithgoutandnephrolithiasis AT viktoriageorgiyevnabarskova clinicalexperiencewithuralytuusedinpatientswithgoutandnephrolithiasis |
| _version_ |
1721335413473280000 |